Article Name: Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy
What are the takeaway points from this article?
Teleophthalmology is a rapidly growing field with applications for screening, evaluation and even remote off-line therapeutic management of eye diseases and conditions. This study is the first application of real-time therapeutic intervention through remote computer control of an automated laser device connected to a fifth-generation wireless network. A total of 6 patients (9 eyes) with diabetic retinopathy underwent remote laser photocoagulation with no report of delays during treatment or adverse events during photocoagulation and no significant change in visual acuity 1-month post op (2 eyes lost to follow-up due to COVID-19 pandemic). The authors recognize that a randomized clinical trial will be necessary to compare outcomes of in-person and remote real-time procedures for wide-spread adaptation. However, as access to technology continues to evolve, this gives a glimpse into future clinical utility for patients in remote areas and the expansion of global health initiatives to areas where specialists are limited.
Chen H, Pan X, Yang J, Fan J, Qin M, Sun H, et al. Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy. JAMA Ophthalmol [Internet]. 2021 [cited 2021 Sep 11]; Available from: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2781796
Date Published: July 8, 2021
Summary By: Brooklyn Rawlyk